| 产品描述: | KR-39038 is an orally active and potent GRK5 (G protein-coupled receptor kinase 5) inhibitor, with an IC50 of 0.02 μM. KR-39038 significantly inhibits angiotensin II-induced cellular hypertrophy through suppression of HDAC5 pathway in neonatal cardiomyocytes. KR-39038 shows profound anti-hypertrophic effects and improved cardiac function. KR-39038 can be used for heart failure research. |
| 靶点: |
HDAC5 |
| 体外研究: |
KR-39038 (0-30 mg/kg, Orally, once daily for 14 days) effectively attenuates both cardiac hypertrophy and dysfunction in experimental heart failure.
Pharmacokinetic Parameters of KR-39038 in Sprague-Dawley rats. |
| 体内研究: |
KR-39038 (0-1.0 μM, 24 h) significantly inhibits angiotensin II-induced cellular hypertrophy and HDAC5 phosphorylation in neonatal cardiomyocytes. |
| 保存条件: |
-80°C 6个月; -20°C 1个月,氮气保存 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.105 ml |
10.526 ml |
21.053 ml |
| 5 mM |
0.421 ml |
2.105 ml |
4.211 ml |
| 10 mM |
0.211 ml |
1.053 ml |
2.105 ml |
| 50 mM |
0.042 ml |
0.211 ml |
0.421 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |